Final Agenda Now Available

Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's interests by going back and forth among concurrent tracks. Last year's event was our largest ever! For more, see our testimonial video and photo gallery below:

   » Testimonial Video   » Photo Gallery   » Attendee List

For 2025, early speakers from Top Pharma include: AbbVie, Amgen, AstraZeneca, Biogen, Genentech, GlaxoSmithKline, Johnson & Johnson Innovative Medicine, Merck, Novartis, Pfizer, Sanofi, and more.

For maximum savings, reserve your spot by December 13. Bring a team to San Diego and SAVE 20% with a Group registration.


Submit a Speaker Proposal
Download Brochure
Submit a Poster


2024 Plenary Keynotes

Barry Sharpless, PhD

Applications of SuFEx Click Chemistry for Drug Discovery and Chemical Biology

Barry Sharpless, PhD

Professor, Chemistry, Scripps Research Institute
2022 and 2001 Nobel Laureate

Daniel Nomura, PhD

Reimagining Druggability Using Chemoproteomic Platforms

Daniel Nomura, PhD

Professor of Chemical Biology and Molecular Therapeutics, Department of Chemistry, University of California, Berkeley

2025 PREMIER SPONSOR

Wuxi-Apptec

2025 CORPORATE SPONSORS

Curia Pelago Selvita Xtalpi
About Drug Discovery Chemistry Video

ABOUT THE EVENT

Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic event for medicinal and biophysical chemists working in pharma, biotech & academia, and will feature:

  • 200 presentations
  • 900 high-level participants from 25+ countries
  • 100 industry-leading sponsors & exhibitors
  • 90+ posters
  • 30+ talks from top pharma
  • Dedicated networking opportunities
  • Interactive breakout & panel discussions
  • The ability to "track-hop" between concurrent meetings
  • Exclusive exhibit & poster viewing hours